Our Co-Founder Dr Lara Zibners will be at the Women’s Health Innovation USA 2024 summit in Boston to talk about the exciting vaginal microbiome space as part of the panel “Unlocking the Potential of the Vaginal Microbiome”.

The advancing science is becoming impossible to ignore: reproductive tract dysbiosis or the lack of a healthy vaginal microbiome affects conditions from cancer, PCOS, pregnancy loss, preterm birth, infertility, endometriosis, and HPV. Lara will share how our Callavid drug delivery platform is poised to play a pivotal role in advancing the field by enabling the convenient and effective delivery of live biotherapeutics.